Cargando…
Advancements in the treatment of mycosis fungoides and Sézary syndrome: monoclonal antibodies, immunotherapies, and Janus kinase inhibitors
Mycosis fungoides (MF) and Sézary syndrome (SS) are forms of cutaneous T cell lymphoma (CTCL) that pose significant challenges in their clinical management, particularly in refractory and advanced-stage disease. With the emergence of novel therapeutic modalities however, there are increasing opportu...
Autores principales: | Quadri, Iman, Reneau, John C., Hanel, Walter, Chung, Catherine G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654973/ https://www.ncbi.nlm.nih.gov/pubmed/38022633 http://dx.doi.org/10.3389/fimmu.2023.1291259 |
Ejemplares similares
-
Mycosis fungoides and Sézary syndrome
por: Jonak, Constanze, et al.
Publicado: (2021) -
Mycosis fungoides and Sézary syndrome
por: Lee, Hyewon
Publicado: (2023) -
The utility of bexarotene in mycosis fungoides and Sézary syndrome
por: Panchal, Manisha R, et al.
Publicado: (2015) -
TOX Expression in Mycosis Fungoides and Sezary Syndrome
por: Pileri, Alessandro, et al.
Publicado: (2022) -
The Role of Tumor Microenvironment in Mycosis Fungoides and Sézary Syndrome
por: Liu, Zhaorui, et al.
Publicado: (2021)